# Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion

> **NCT00435305** · — · TERMINATED · sponsor: **University Hospital Tuebingen** · enrollment: 40 (estimated)

## Conditions studied

- Pneumonia
- Bacteremia

## Interventions

- **DRUG:** Meropenem
- **DRUG:** Vancomycin
- **DRUG:** Linezolid
- **DRUG:** Piperacillin/Tazobactam
- **DRUG:** Cefepim
- **DRUG:** Ceftazidim

## Key facts

- **NCT ID:** NCT00435305
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** difficulties by enrolling patients fundings consumed, no staff could be recruited and payed to continue enrolling patients,
- **Last updated:** 2008-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435305, "Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00435305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*